SEC Form D · filed October 2, 2023
NurExone Biologic Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Michael K. Mckenna · VANCOUVER, British Columbia, CanadaExec · DirectorScott Taylor · VANCOUVER, British Columbia, CanadaDirectorLior Shaltiel · Bnei-Brak, L3Exec · DirectorAnton F. Klaveness · VANCOUVER, British Columbia, CanadaDirectorChristopher K. Green · VANCOUVER, British Columbia, CanadaDirectorOded 4. Orgil · Bnei-Brak, L3DirectorMichael F. Westlake · VANCOUVER, British Columbia, CanadaExecOded 4. Orgil · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecYoram 4. Drucker · Bnei-Brak, L3DirectorGadi Riesenfeld · Bnei-Brak, L3DirectorGadi Riesenfeld · Bnei-Brak, L3DirectorJames 4. Richardson · Bnei-Brak, L3DirectorEran Ovadya · Bnei-Brak, L3ExecLior Shaltiel · Bnei-Brak, L3Exec · DirectorJoseph K. Fuqua · VANCOUVER, British Columbia, CanadaDirectorJames 4. Richardson · Bnei-Brak, L3DirectorYoram 4. Drucker · Bnei-Brak, L3Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗